| 1 |
Xia Y, Wang Y, Xiao Y, Shan M, Hao Y, Zhang L. Identification of a Diagnostic Signature and Immune Cell Infiltration Characteristics in Keloids. Front Mol Biosci 2022;9:879461. [DOI: 10.3389/fmolb.2022.879461] [Reference Citation Analysis]
|
| 2 |
Kaltenmeier C, Simmons RL, Tohme S, Yazdani HO. Neutrophil Extracellular Traps (NETs) in Cancer Metastasis. Cancers (Basel) 2021;13:6131. [PMID: 34885240 DOI: 10.3390/cancers13236131] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 3 |
Liu S, Sun X, Li K, Zha R, Feng Y, Sano T, Dong C, Liu Y, Aryal UK, Sudo A, Li BY, Yokota H. Generation of the tumor-suppressive secretome from tumor cells. Theranostics 2021;11:8517-34. [PMID: 34373756 DOI: 10.7150/thno.61006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 4 |
Mielczarek-Palacz A, Kondera-Anasz Z, Smycz-Kubańska M. Changes in the Concentration of Markers Participating in the Regulation of the Apoptosis Receptor Pathway Involving Soluble Tumour Necrosis Factor Ligand inducing Apoptosis (sTRAIL) and Osteoprotegerin (OPG) in the Serum of Women with Ovarian Cancer-Participation in Pathogenesis or a Possible Clinical Use? Cells 2020;9:E612. [PMID: 32143328 DOI: 10.3390/cells9030612] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 5 |
Ion GND, Nitulescu GM, Popescu CI. Targeting TRAIL. Bioorg Med Chem Lett 2019;29:2527-34. [PMID: 31383590 DOI: 10.1016/j.bmcl.2019.07.053] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 6 |
Walters KA, Zhu R, Welge M, Scherler K, Park JK, Rahil Z, Wang H, Auvil L, Bushell C, Lee MY, Baxter D, Bristol T, Rosas LA, Cervantes-Medina A, Czajkowski L, Han A, Memoli MJ, Taubenberger JK, Kash JC. Differential Effects of Influenza Virus NA, HA Head, and HA Stalk Antibodies on Peripheral Blood Leukocyte Gene Expression during Human Infection. mBio 2019;10:e00760-19. [PMID: 31088926 DOI: 10.1128/mBio.00760-19] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 7 |
Ajala O, Zhang Y, Gupta A, Bon J, Sciurba F, Chandra D. Decreased serum TRAIL is associated with increased mortality in smokers with comorbid emphysema and coronary artery disease. Respir Med 2018;145:21-7. [PMID: 30509711 DOI: 10.1016/j.rmed.2018.10.018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 8 |
Beauséjour M, Boutin A, Vachon PH. Anoikis Regulation: Complexities, Distinctions, and Cell Differentiation. Apoptosis and Beyond 2018. [DOI: 10.1002/9781119432463.ch8] [Reference Citation Analysis]
|
| 9 |
Abd El-aziz SM, Alkhiary W, Mokhtar N, Talaab M. Tumor necrosis factor-α (TNF-α) −308 G/A and lymphotoxin-α (LT-α) +252 A/G genetic polymorphisms in Egyptian acute lymphoblastic leukemia. Comp Clin Pathol 2018;27:363-9. [DOI: 10.1007/s00580-017-2600-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 10 |
Wang X, Fang G, Pang Y. Chinese Medicines in the Treatment of Prostate Cancer: From Formulas to Extracts and Compounds. Nutrients 2018;10:E283. [PMID: 29495626 DOI: 10.3390/nu10030283] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 11 |
Pan ST, Li ZL, He ZX, Qiu JX, Zhou SF. Molecular mechanisms for tumour resistance to chemotherapy. Clin Exp Pharmacol Physiol 2016;43:723-37. [PMID: 27097837 DOI: 10.1111/1440-1681.12581] [Cited by in Crossref: 222] [Cited by in F6Publishing: 238] [Article Influence: 37.0] [Reference Citation Analysis]
|
| 12 |
Ma S, Sun J, Guo Y, Zhang P, Liu Y, Zheng D, Shi J. Combination of AAV-TRAIL with miR-221-Zip Therapeutic Strategy Overcomes the Resistance to TRAIL Induced Apoptosis in Liver Cancer. Theranostics 2017;7:3228-42. [PMID: 28900506 DOI: 10.7150/thno.19893] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 13 |
Lim SC, Han SI. MDL-12330A potentiates TRAIL-induced apoptosis in gastric cancer cells through CHOP-mediated DR5 upregulation. Korean J Physiol Pharmacol 2017;21:397-405. [PMID: 28706453 DOI: 10.4196/kjpp.2017.21.4.397] [Reference Citation Analysis]
|
| 14 |
Lim SC, Han SI. MDL-12330A potentiates TRAIL-induced apoptosis in gastric cancer cells through CHOP-mediated DR5 upregulation. Korean J Physiol Pharmacol 2017;21:397-405. [PMID: 28706453 DOI: 10.4196/kjpp.2017.21.4.397] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 15 |
Liu C, Zheng M, Zhang T, Fu R, Wang H, Wang T, Qi W, Shao Z. TRAIL in CD8+ T cells from patients with severe aplastic anemia. Int J Hematol 2017;106:490-9. [PMID: 28631177 DOI: 10.1007/s12185-017-2279-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 16 |
Xu YM, Brooks AD, Wijeratne EM, Henrich CJ, Tewary P, Sayers TJ, Gunatilaka AA. 17β-Hydroxywithanolides as Sensitizers of Renal Carcinoma Cells to Tumor Necrosis Factor-α Related Apoptosis Inducing Ligand (TRAIL) Mediated Apoptosis: Structure-Activity Relationships. J Med Chem 2017;60:3039-51. [PMID: 28257574 DOI: 10.1021/acs.jmedchem.7b00069] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 17 |
Cadamuro M, Brivio S, Spirli C, Joplin RE, Strazzabosco M, Fabris L. Autocrine and Paracrine Mechanisms Promoting Chemoresistance in Cholangiocarcinoma. Int J Mol Sci 2017;18:E149. [PMID: 28098760 DOI: 10.3390/ijms18010149] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 18 |
Roesler S, Eckhardt I, Wolf S, Fulda S. Cooperative TRAIL production mediates IFNα/Smac mimetic-induced cell death in TNFα-resistant solid cancer cells. Oncotarget 2016;7:3709-25. [PMID: 26788912 DOI: 10.18632/oncotarget.6915] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 19 |
Zhou W, Feng X, Han Han, Guo S, Wang G. Synergistic effects of combined treatment with histone deacetylase inhibitor suberoylanilide hydroxamic acid and TRAIL on human breast cancer cells. Sci Rep 2016;6:28004. [PMID: 27292433 DOI: 10.1038/srep28004] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 20 |
Tewary P, Gunatilaka AA, Sayers TJ. Using natural products to promote caspase-8-dependent cancer cell death. Cancer Immunol Immunother 2017;66:223-31. [PMID: 27286684 DOI: 10.1007/s00262-016-1855-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 21 |
Varn FS, Andrews EH, Mullins DW, Cheng C. Integrative analysis of breast cancer reveals prognostic haematopoietic activity and patient-specific immune response profiles. Nat Commun 2016;7:10248. [PMID: 26725977 DOI: 10.1038/ncomms10248] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 22 |
Uribe-Querol E, Rosales C. Neutrophils in Cancer: Two Sides of the Same Coin. J Immunol Res 2015;2015:983698. [PMID: 26819959 DOI: 10.1155/2015/983698] [Cited by in Crossref: 191] [Cited by in F6Publishing: 215] [Article Influence: 23.9] [Reference Citation Analysis]
|
| 23 |
Amarante-Mendes GP, Griffith TS. Therapeutic applications of TRAIL receptor agonists in cancer and beyond. Pharmacol Ther 2015;155:117-31. [PMID: 26343199 DOI: 10.1016/j.pharmthera.2015.09.001] [Cited by in Crossref: 50] [Cited by in F6Publishing: 56] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 24 |
Bil-Lula I, Krzywonos-Zawadzka A, Sawicki G, Woźniak M. An infection of human adenovirus 31 affects the differentiation of preadipocytes into fat cells, its metabolic profile and fat accumulation. J Med Virol 2016;88:400-7. [PMID: 26297921 DOI: 10.1002/jmv.24362] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 25 |
Timirci-Kahraman O, Ozkan NE, Turan S, Farooqi AA, Verim L, Ozturk T, Inal-Gultekin G, Isbir T, Ozturk O, Yaylim I. Genetic variants in the tumor necrosis factor-related apoptosis-inducing ligand and death receptor genes contribute to susceptibility to bladder cancer. Genet Test Mol Biomarkers 2015;19:309-15. [PMID: 25955868 DOI: 10.1089/gtmb.2015.0050] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 26 |
Trivedi R, Mishra DP. Trailing TRAIL Resistance: Novel Targets for TRAIL Sensitization in Cancer Cells. Front Oncol 2015;5:69. [PMID: 25883904 DOI: 10.3389/fonc.2015.00069] [Cited by in Crossref: 131] [Cited by in F6Publishing: 156] [Article Influence: 16.4] [Reference Citation Analysis]
|
| 27 |
Henrich CJ, Brooks AD, Erickson KL, Thomas CL, Bokesch HR, Tewary P, Thompson CR, Pompei RJ, Gustafson KR, McMahon JB, Sayers TJ. Withanolide E sensitizes renal carcinoma cells to TRAIL-induced apoptosis by increasing cFLIP degradation. Cell Death Dis 2015;6:e1666. [PMID: 25719250 DOI: 10.1038/cddis.2015.38] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 5.1] [Reference Citation Analysis]
|
